Amel is a scientist with Immunology and cellular biology background, experienced in cell therapy development from R&D to clinical phase, Business Development and Company Development strategy. Continuous learning and training on the Managerial and Entrepreneurial aspect of the Biotech Industry. 

Prior experience:

•    Investment Manager, Noshaq (2021)
•    COO and QC Director at TEXERE Biotech (2017-2020)
•    Development & Project Manager at Masthercell (2014-2017)
•    Project & Business Development Manager at Analis (2014-2014)
•    Project Leader at Cardio3 Biosciences (2013-2014)
•    R&D Scientist at Cardio3 Biosciences (2011-2013)
•    Post-Doc at the German Cancer Research Center (DKFZ) (2009-2011)

Education:

•    EMBA at Solvay Business School (2019-2021)
•    PhD in Biomedical and Pharmaceutical Sciences in the field of immunology and genetics, Université catholique de Louvain
•    Postgraduate degree (DEA) in Health Sciences, Biomedical Sciences, Université catholique de Louvain (magna cum laude), Belgium
•    Masters degree in Cellular Biology and Physiology, Université Louis Pasteur, Strasbourg, France